SE OF KASISADI VAGINAL PESSARY and UDUMBARADI TAIL PICCHU In ABNORMAL VAGINAL DISCHARGE
Phase 3
Completed
- Conditions
- Health Condition 1: N949- Unspecified condition associated with female genital organs and menstrual cycle
- Registration Number
- CTRI/2021/04/032874
- Lead Sponsor
- RGG PG AYURVEDIC COLLEGE And HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 210
Inclusion Criteria
Patient willing for the trial and ready to give consent.
Married female patients/Sexually active patients
Patient complaining shewtapradar abnormal vaginal discharge as a major symptom.
Exclusion Criteria
Patient willing for the trial and ready to giv
Unmarried women
Pregnancy
Certain Gynecological pathologies like CA cervix ,fibroid polyp etc.
HIV positive patients.
Diabetic and Severly Anemic patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To cure abnormal vaginal dischargeTimepoint: 7 days
- Secondary Outcome Measures
Name Time Method Improve quality of lifeTimepoint: 14 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Kasisadi Vaginal Pessary in SHWETA PRADAR management?
How does Udumbaradi Tail Pichhu compare to standard-of-care treatments for abnormal vaginal discharge in terms of clinical outcomes?
Are there specific biomarkers associated with response to Kasisadi and Udumbaradi interventions in N949-related conditions?
What adverse events have been reported with Kasisadi Vaginal Pessary and Udumbaradi Tail Pichhu in phase III trials?
What are the potential synergistic effects of combining Kasisadi Vaginal Pessary with other Ayurvedic or conventional therapies for SHWETA PRADAR?